How much funding has Cavos Bio raised?

Cavos Bio has raised $3.4M in total funding, most recently a Seed round.

Who are Cavos Bio's investors?

Cavos Bio's investors include Alumni Ventures.

Where is Cavos Bio headquartered?

Cavos Bio is headquartered in Jerusalem, Israel.

Cavos Bio

Validated by nature

Jerusalem, Israel · Founded 2021 · $3.4M raised

Biotech

Headquarters: Jerusalem
Employees: 1–10
Founded: 2021
Business Model: B2B

Total Funding: $3.4M
Last Round: $3.4M SeedNov 2024
Rounds: 1

About

caVos Biotherapeutics is a preclinical biotech startup founded out of The Hebrew University of Jerusalem. The company uses a multi-level genomic algorithm and comparative genomics to identify the genetic basis of extraordinary cancer resistance observed across various animal species, with the goal of uncovering novel anti-cancer drug targets and mRNA therapeutics. caVos leverages advanced data science and AI to translate nature's own cancer-resistance mechanisms into precision medicine drug candidates, targeting both oncology and longevity-related indications such as fibrosis. The company was recognized as one of the Most Innovative Life Science Startups at Biomed Israel 2026.

Summary

Cavos Bio is a Biotech company based in Jerusalem, Israel, founded in 2021. It has raised $3.4M in total across 1 round, most recently a $3.4M Seed round in Nov 2024. Investors include Alumni Ventures.